Edge Wealth Management LLC Viking Therapeutics, Inc. Transaction History

Edge Wealth Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 20, 2020	SELL	$3.45 - $7.95 $345 - $795	-100 Closed	0 $0
Q2 2019 Jul 15, 2019	SELL	$7.67 - $10.63 $38 - $53	-5 Reduced 4.76%	100 $1,000
Q1 2019 Apr 11, 2019	BUY	$7.58 - $9.94 $758 - $994	100 Added 2000.0%	105 $1,000
Q3 2018 Oct 22, 2018	BUY	$9.7 - $19.65 $48 - $98	5 New	5 $1,000

442

63.3M

6.23M

2.97M

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $4.86B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Edge Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Edge Wealth Management LLC with notifications on news.